MDxHealth Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for MDxHealth stock have an average target of 7.67, with a low estimate of 7.00 and a high estimate of 9.00. The average target predicts an increase of 275.98% from the current stock price of 2.04.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$7.67	$7.00	$9.00
Change	+243.14%	+275.98%	+243.14%	+341.18%

* Price targets were last updated on Dec 23, 2025.

Analyst Ratings

The average analyst rating for MDxHealth stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mark Massaro BTIG	BTIG	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+243.14%	Dec 23, 2025
Dan Brennan TD Cowen	TD Cowen	Strong Buy Maintains $5 → $7	Strong Buy	Maintains	$5 → $7	+243.14%	Nov 13, 2025
Thomas Flaten Lake Street	Lake Street	Strong Buy Maintains $7 → $9	Strong Buy	Maintains	$7 → $9	+341.18%	Nov 13, 2025
Mark Massaro BTIG	BTIG	Strong Buy Maintains $6 → $7	Strong Buy	Maintains	$6 → $7	+243.14%	Nov 13, 2025
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $8 → $6	Buy	Maintains	$8 → $6	+194.12%	Nov 7, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

141.08M

from 107.88M

30.78%

from 107.88M

Revenue Next Year

166.91M

from 141.08M

18.31%

from 141.08M

EPS This Year

-0.43

from -0.67

EPS Next Year

-0.16

from -0.43

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	22.24M	37.05M	70.19M	90.05M	107.88M	141.08M	166.91M
Revenue Growth	20.47%	66.62%	89.43%	28.29%	19.80%	30.78%	18.31%
EPS	-2.38	-2.78	-1.66	-1.16	-0.67	-0.43	-0.16
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	147.0M	173.7M
Avg	141.1M	166.9M
Low	134.4M	157.4M

Revenue Growth

Revenue Growth	2026	2027
High	36.3%	23.1%
Avg	30.8%	18.3%
Low	24.6%	11.6%

EPS Forecast

EPS	2026	2027
High	-0.30	-0.05
Avg	-0.43	-0.16
Low	-0.57	-0.26

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.